Evidence Hub

Hypovitaminosis D-Induced Secondary Hyperparathyroidism With Concomitant Femoral Fracture in a Chronic Hepatitis B Patient: A Case Report

Appati W, Hutton-Mensah KA, Aidoo L, Otchwemah NAS

Clinical case reports, 2026

Abstract

Vitamin D deficiency and secondary hyperparathyroidism (SHPT) are preventable causes of metabolic bone disease, yet they may remain clinically silent until catastrophic skeletal events occur. Chronic hepatitis B virus (HBV) infection has been increasingly linked to disordered bone and mineral metabolism, even in the absence of cirrhosis. We report a 39-year-old man with chronic HBV infection who presented with a low-trauma subtrochanteric femoral fracture. He had no history of alcohol or tobacco use and had only recently commenced antiviral therapy. Biochemical evaluation revealed severe vitamin D deficiency, markedly elevated parathyroid hormone levels, hypophosphatemia, and raised alkaline phosphatase, consistent with SHPT and metabolic bone disease. There was no clinical or radiological evidence of liver cirrhosis. The patient underwent surgical fixation of the fracture, received vitamin D supplementation, and was initiated on Tenofovir Alafenamide, with good clinical recovery.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free